VI Technologies' Acquisition

VI Technologies was acquired by Panacos Pharmaceuticals on March 08, 2005.

Vitex is developing products designed to improve the safety of the world's blood supply. The Company's proprietary INACTINE technology, currently in a Phase III clinical trial, is designed to inactiva…

Articles about VI Technologies' Acquisition: